A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis
Clinical trial NCT06558279 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06558279
- Sponsor
- argenx
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-18
- Primary completion
- 2026-01-12
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.